Latest news with #Pomol-650
News18
2 days ago
- Health
- News18
Paracetamol Brand Pomol-650 Among 15 Medicines Found Unsafe, Banned In Karnataka
Last Updated: Karnataka's food safety and drugs regulator said chemists, wholesalers, doctors, hospitals, and nursing homes should not stock, sell, or use these drugs and cosmetics The Karnataka government on Thursday banned the use of 15 medicines, including a brand of paracetamol, after they were found unsafe by the state's food safety regulator. Paracetamol brand Pomol-650 (paracetamol tablets IP 650 mg) and O Shanti Gold Class Kumkum manufactured in Mysuru are among the 15 medicines found unfit for use, said a circular from the state food safety and drug administration. According to the circular, food safety and drug control under the health department had collected samples of different pharmaceutical and cosmetic products in May. Upon testing, 15 products were found unfit for use, and a warning has been issued to stakeholders. The official statement said the chemists, wholesalers, doctors, hospitals, and nursing homes should not stock, sell, or use these drugs and cosmetics. Earlier, the state government's drug testing laboratory declared these drugs manufactured by different companies as 'substandard". 'In case they hold any stock, they are requested to inform the concerned area drugs inspector or assistant drugs controller. The public is also advised not to use these drugs or cosmetics," the statement read. Other substandard drugs on the list include compound sodium lactate injection IP (Ringer-Lactate solution for injection) manufactured by Ultra Laboratories (batch no: KI124110) and Tam Bran Pharmaceuticals and MITO Q7 Syrup by Bion Therapeutics India (batch no: CHS-40170) among others. The department has urged strict compliance with these directions to safeguard public health. (With PTI inputs) First Published: June 26, 2025, 17:02 IST
India Today
2 days ago
- Health
- India Today
Karnataka bans 15 medicines including Mysuru-made paracetamol after test failure
The Karnataka State Department of Food Safety and Drug Control banned the use and distribution of 15 pharmaceutical and cosmetic products, including a commonly used paracetamol brand, after tests found them to be unsafe. A circular issued by the department, which operates under the state Health Department, confirmed the findings following sample tests conducted in May the banned products is Pomol-650, a paracetamol tablet manufactured by Aban Pharmaceuticals Pvt. Ltd. in Mysuru, and O Shanti Gold Class Kumkum, produced by N Ranga Rao & Sons Pvt. Ltd., also based in Mysuru. The list includes a range of injectable solutions, syrups, tablets, and even a veterinary vaccine Other banned items include Compound Sodium Lactate Injection IP produced by Ultra Laboratories Pvt. Ltd. and Tom Bron Pharmaceuticals Pvt. Ltd., Mitu Q7 Syrup by Bion Therapeutics, Pantocot-DSR capsules by Svefn Pharmaceuticals, and Sodium Chloride Injection IP 0.9% w/v by Puniska Injectables Pvt. products such as sterile diluents for poultry vaccines by Safe Parenterals Pvt. Ltd., and various other formulations like Glimiz-2 (glimepiride tablets), Iron Sucrose Injection (Irogain), and Pyracid-O Suspension were also listed as unfit for have directed that these products should neither be used nor distributed until further instructions are issued. The circular urged healthcare providers, pharmacies, and the general public to ensure immediate compliance to safeguard public health.- Ends IN THIS STORY#Karnataka
Hans India
2 days ago
- Health
- Hans India
Karnataka govt flags 14 substandard drugs; tells chemists, docs, public to avoid them
Bengaluru: The Karnataka government's Drug Testing Laboratory declared 14 drugs manufactured by 14 different companies as 'substandard' on Wednesday. The state's Food Safety and Drug Administration department has directed chemists, wholesalers, doctors, hospitals, and nursing homes not to stock, sell, or use these drugs and cosmetics, an official statement said. 'In case they hold any stock, they are requested to inform the concerned area Drugs Inspector or Assistant Drugs Controller. The public is also advised not to use these drugs or cosmetics,' the statement added. The substandard drugs include compound sodium lactate injection IP (Ringer-Lactate solution for injection) manufactured by Ultra Laboratories (batch no: KI124110) and Tam Bran Pharmaceuticals; Pomol-650 (Paracetamol tablets I P 650 mg) by Aban Pharmaceuticals (batch no: 13-4536) and MITO Q7 Syrup by Bion Therapeutics India (batch no: CHS-40170) among others. The department has urged strict compliance with these directions to safeguard public health.
Mint
3 days ago
- Health
- Mint
Karnataka warns people against 14 ‘substandard' drugs; directs sellers not to stock or sell THESE medicines
The Karnataka government declared 14 drugs manufactured by different companies 'substandard' on Wednesday, 25 June 2025, and warned people against the public consumption of the same, reported the news agency PTI. The Karnataka Food Safety and Drug Administration department ordered the chemists, wholesalers, doctors, hospitals, and nursing homes not to keep stock of these drugs, and also directed against selling or usage of these medicines and cosmetics, according to the agency report citing the official statement. 'In case they hold any stock, they are requested to inform the concerned area Drugs Inspector or Assistant Drugs Controller. The public is also advised not to use these drugs or cosmetics,' said the FSDA department, according to the agency report. 1. Compound sodium lactate injection IP (Ringer-Lactate solution for injection) — Manufactured by Ultra Laboratories (batch no: KI124110) and Tam Bran Pharmaceuticals. 2. Pomol-650 (Paracetamol tablets I P 650 mg) by Aban Pharmaceuticals (batch no: 13-4536). 3. MITO Q7 Syrup by Bion Therapeutics India (batch no: CHS-40170). These are among the 14 drugs which were marked as 'substandard' by the Karnataka Food Safety and Drug Administration department on Wednesday, 25 June 2025. The department also requested strict compliance to be imposed on these companies and drugs to safeguard public health, reported the news agency. According to Mint's earlier report, India is aiming to give a significant boost to its production-linked incentive (PLI) schemes for drug manufacturing to reduce the nation's pharma sector dependence on China imports. The updated PLI scheme will include more molecules used in manufacturing key starting materials (KSMs), drug intermediates, and active pharmaceutical ingredients (APIs), according to the 3 June 2025 report citing official communication. Details on such incentives as allocation, capacity, and incentive ceiling for the upgraded drug PLI scheme are being worked on, according to the Mint's report, citing a department official.
The Print
3 days ago
- Health
- The Print
Karnataka govt flags 14 substandard drugs; tells chemists, docs, public to avoid them
'In case they hold any stock, they are requested to inform the concerned area Drugs Inspector or Assistant Drugs Controller. The public is also advised not to use these drugs or cosmetics,' the statement added. The state's Food Safety and Drug Administration department has directed chemists, wholesalers, doctors, hospitals, and nursing homes not to stock, sell, or use these drugs and cosmetics, an official statement said. Bengaluru, Jun 25 (PTI) The Karnataka government's Drug Testing Laboratory declared 14 drugs manufactured by 14 different companies as 'substandard' on Wednesday. The substandard drugs include compound sodium lactate injection IP (Ringer-Lactate solution for injection) manufactured by Ultra Laboratories (batch no: KI124110) and Tam Bran Pharmaceuticals; Pomol-650 (Paracetamol tablets I P 650 mg) by Aban Pharmaceuticals (batch no: 13-4536) and MITO Q7 Syrup by Bion Therapeutics India (batch no: CHS-40170) among others. The department has urged strict compliance with these directions to safeguard public health. PTI GMS GMS SSK This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
